Lungs | UT Southwestern Medical Center

MedBlog

Lungs

Lungs; Prevention

Robotic bronchoscopy offers minimally invasive, earlier lung cancer diagnosis

Kim Styrvoky, M.D.
Muhanned Abu-Hijleh, M.D.

May 4, 2022

Latest

Lung transplant team provides relief for patients post-COVID-19

January 17, 2022

Landmark cystic fibrosis clinical trial gives patients hope for healthy pregnancies

June 15, 2021

Nonsurgical valve treatment provides relief for patients with severe emphysema

June 2, 2021

Lung cancer in young nonsmokers is on the rise: Uncovering the cause

March 12, 2021

Life cycle of a coronavirus: How respiratory illnesses harm the body

April 2, 2020

Not a cure, but an extension: How immunotherapy works for advanced lung cancer

Data released in April 2018 suggest that adding immunotherapy to chemotherapy can extend the lives of some advanced lung cancer patients. Discover how immunotherapy works and who might benefit.

David Gerber, M.D.

May 3, 2018

Lungs; Transplant

Why lung transplant rejection is more normal – and treatable – than most think

Acute rejection of a lung transplant is surprisingly normal; 40 to 50 percent of transplant patients deal with it during the first year after surgery. Discover why Dr. Fernando Torres says these rejections are very treatable through medication at home or at the doctor’s office.

Fernando Torres, M.D.

October 11, 2018

Lungs; Transplant

When a doctor may recommend lung transplant to treat COPD, emphysema, or pulmonary fibrosis

Lung diseases can have major negative effects on patients’ quality of life. Learn about when we recommend a lung transplant to treat these conditions.

Fernando Torres, M.D.

October 11, 2017

Discovery; Lungs; Transplant

Cystic fibrosis breakthrough: 3-drug combo pill may benefit 90% of patients

A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.